Spravato
A NEW OPTION FOR TREATMENT-RESISTANT DEPRESSION
Spravato Treatment
Spravato (esketamine) is an FDA-approved nasal spray for adults with major depressive disorder (MDD) that has not improved with at least two antidepressants.
FDA-Approved Treatment
For Treatment Resistant Depression
In-office Administration & Monitoring
Care From an Experienced Team
WHAT IS SPRAVATO?
Understanding The Treatment
Spravato is a nasal spray containing esketamine, a medication that works differently than traditional antidepressants. It targets the brain’s glutamate system, which can help improve depressive symptoms, often within hours to days.
Schedule a consultation with Michelle Dela Pena to discuss expectations, benefits, and risks, and explore whether Spravato treatment is right for you.
THE PROCESS
What To Expect
Spravato is prescribed as part of a comprehensive treatment plan, which includes in-office administration and monitoring by our trained medical team.
Assessment
A thorough evaluation to determine if Spravato is right for you.
Treatment
Administered in office, under supervision, typically twice per week at first.
Monitoring
You’ll be monitored for about two hours after each treatment to ensure safety.
POSSIBLE SIDE EFFECTS
Side Effects
Like any medication, Spravato can cause side effects. Common side effects may include:
You must arrange for a friend or family member to drive you home after each treatment.
ACCESS OUR
Spravato Patient Forms
READY TO LEARN MORE?
See if spravato is right for you
Schedule a consultation with our team to discuss you symptoms, treatment history, and whether Spravato may be a good fit.